Document is current
Any future updates will be listed below
-
Authors
,
van den Berg, Sophie A. https://orcid.org/0000-0001-6437-6486
Dippel, Diederik W. J.
Hofmeijer, Jeannette
Fransen, Puck S. S.
Caminada, Klaartje
Siegers, Arjen
Kruyt, Nyika D.
Kerkhoff, Henk
de Leeuw, Frank-Erik
Nederkoorn, Paul J.
van der Worp, H. Bart
-
Funding
Funding for this research was provided by:
Hartstichting (CVON2015-01: CONTRAST)
Hersenstichting (HA2015.01.06)
Top Sector Life Sciences & Health (LSHM17016)
Health~Holland
Medtronic
- License Information
-
More Information
Article History
Received: 29 November 2018
Accepted: 9 May 2019
First Online: 26 June 2019
Ethics approval and consent to participate
: Central ethical approval has been confirmed from the medical ethics committee and research board of Erasmus MC University Medical Center (ref approval no. 10/19/2017, MEC-2017-369). Local ethical approval has been obtained at all participating centres. We will not begin recruiting at other centres in the trial until local ethical approval has been confirmed. Informed consent will be obtained from all study participants.
: Not applicable.
: The CONTRAST consortium is supported by Netherlands Cardiovascular Research Initiative, an initiative of the Dutch Heart Foundation, by the Brain Foundation Netherlands and powered by Health~Holland, Top Sector Life Sciences and receives unrestricted funding from Medtronic.HW has received speaker’s fees from Boehringer Ingelheim and Bayer, and serves as a consultant to Boehringer Ingelheim.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
